secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-01-05T23:59:59+00:00
Accession:  0001575872-23-000023
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. extends business combination deadline to July 19, 2023; 3.52M shares redeemed
--------------------------------------------------------------------------------

- Stockholders approved extension of deadline from Jan 19, 2023 to July 19, 2023 at special meeting on Dec 22, 2022.
- On Dec 29, 2022, company filed charter amendment and entered into trust agreement amendment to effect the extension.
- In connection with extension vote, 3,519,780 shares of common stock were redeemed.
- Trust account holds $45,186,000 from offering and private placement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000023/0001575872-23-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000023/uptd-20221229.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer